Singapore markets closed

Bolt Biotherapeutics, Inc. (BOLT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7350+0.0031 (+0.42%)
At close: 04:00PM EDT
0.7498 +0.01 (+2.01%)
After hours: 05:54PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-63,028
-69,197
-88,098
-98,591
-60,728
-
Depreciation & amortisation
1,845
1,854
1,666
1,193
611
-
Stock-based compensation
9,049
9,223
9,576
8,500
1,420
-
Change in working capital
-9,075
-9,864
-3,057
20,507
-2,283
-
Other working capital
-63,080
-69,731
-78,457
-59,404
-50,570
-
Other non-cash items
3,006
2,952
3,225
8,563
13,638
-
Net cash provided by operating activities
-62,877
-69,525
-76,504
-57,066
-47,308
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-206
-1,953
-2,338
-3,262
-
Purchases of investments
-145,163
-164,988
-180,704
-313,375
-33,229
-
Sales/maturities of investments
197,616
236,232
240,519
83,512
15,899
-
Net cash used for investing activities
52,250
71,038
57,862
-232,201
-20,592
-
Cash flows from financing activities
Debt repayment
-
-
-
-
0
-40
Common stock issued
-
253
503
259,206
294
-
Other financing activities
-
-
-
-
-1,967
-
Net cash used provided by (used for) financing activities
-
253
503
311,108
39,597
-
Net change in cash
-10,374
1,766
-18,139
21,841
-28,303
-
Cash at beginning of period
16,401
10,809
28,948
7,107
35,410
-
Cash at end of period
6,027
12,575
10,809
28,948
7,107
-
Free cash flow
Operating cash flow
-62,877
-69,525
-76,504
-57,066
-47,308
-
Capital expenditure
-
-206
-1,953
-2,338
-3,262
-
Free cash flow
-63,080
-69,731
-78,457
-59,404
-50,570
-